Enfermedad de Krabbe
Definition
Krabbe disease, also called globoid cell leukodystrophy, is an autosomal recessive condition resulting from galactosylceramidase (or galactocerebrosidase) deficiency, a lysosomal enzyme that catabolizes a major lipid component of myelin. Incidence in France is an estimated 1:150,000 births. The disease leads to demyelination of the central and peripheral nervous system. Onset generally occurs during the first year and the condition is rapidly progressive, but juvenile, adolescent or adult onset forms have also been reported, with a more variable rate of progression. The classic infantile form accounts for 85 to 90% of cases. Initial symptoms include increasing irritability, hypertonia, hyperesthesia, and signs of peripheral neuropathy. Later on, hypertonic episodes with opisthotonos occur frequently, and convulsions may appear. As the disease progresses, blindness and deafness occur, followed by a vegetative state, and finally by hypotonia. In the forms with later onset the first signs are often gait disturbancies (spastic paraparesis or ataxia), hemiplegia, visual loss, with or without peripheral neuropathy. Mental deterioration is variable (usually absent in adult forms). The gene coding for galactosylceramidase is located on 14q31 and has been identified. Two mutations are more frequently observed (65% of alleles in France). Diagnosis is established from enzyme assay (galactosylceramidase deficiency). There are several natural animal models (mouse, dog, monkey). Pathognomonic globoid cells are derived from macrophages and induced by non-hydrolysed galactosylceramides. The early destruction of oligodendrocytes is considered to be due to the accumulation of a cytotoxic metabolite (galactosylsphingosine or 'psychosine'). [No translation available]